NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

The head of the U.N. AIDS agency says the number of new HIV infections could jump more than six times by 2029 if American ...

Billionaire Elon Musk's plundering of the US Agency for International Development (USAID) is already proving devastating for ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

GSK was able to offset the decline thanks to a better-than-expected performance for its cancer medicines and HIV therapeutics ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health and more research on other diseases.

Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting ...

The hepatitis B vaccine is a shot, typically injected into the arm, that protects against hepatitis B in babies, children, and adults. It is an important way to protect yourself and your children from ...

H5N1 vaccines have been previously licensed, and millions are in the national stockpile. But even with the news of the country’s first human death due to bird flu, vaccination isn’t yet recommended.

Health Minister Dr Atonio Lalabalavu has declared an outbreak of HIV cases in the country. He says between January and September 2024 Fiji recorded 1093 cases. He revealed the figures during the ...

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

But Scripps Research scientists have now discovered that for some HIV vaccines, something else happens: after a few immunizations the immune system begins to produce antibodies against immune ...